Your browser doesn't support javascript.
loading
AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial.
Molefi, Mooketsi; Chofle, Awilly A; Molloy, Síle F; Kalluvya, Samuel; Changalucha, John M; Cainelli, Francesca; Leeme, Tshepo; Lekwape, Nametso; Goldberg, Drew W; Haverkamp, Miriam; Bisson, Gregory P; Perfect, John R; Letang, Emili; Fenner, Lukas; Meintjes, Graeme; Burton, Rosie; Makadzange, Tariro; Ndhlovu, Chiratidzo E; Hope, William; Harrison, Thomas S; Jarvis, Joseph N.
Afiliação
  • Molefi M; Department of Family Medicine and Public Health, Faculty of Medicine, University of Botswana, P.O.Box 1357 ABG, Gaborone, Botswana. mooketsimolefi@gmail.com.
  • Chofle AA; Botswana-Upenn Partnership, Gaborone, Botswana. mooketsimolefi@gmail.com.
  • Molloy SF; Bugando Medical Centre, Mwanza, Tanzania. awilchofle12@gmail.com.
  • Kalluvya S; National Institute for Medical Research, Mwanza Research Centre, Mwanza, Tanzania. awilchofle12@gmail.com.
  • Changalucha JM; Research Centre for Infection and Immunity, St. George's University of London, London, UK. smolloy@sgul.ac.uk.
  • Cainelli F; Bugando Medical Centre, Mwanza, Tanzania. samuelkalluvya@yahoo.com.
  • Leeme T; National Institute for Medical Research, Mwanza Research Centre, Mwanza, Tanzania. jchangalucha@yahoo.com.
  • Lekwape N; Department of Family Medicine and Public Health, Faculty of Medicine, University of Botswana, P.O.Box 1357 ABG, Gaborone, Botswana. francescacainelli@yahoo.it.
  • Goldberg DW; Botswana-Upenn Partnership, Gaborone, Botswana. tbleeme@yahoo.com.
  • Haverkamp M; Botswana-Upenn Partnership, Gaborone, Botswana. n72823980@gmail.com.
  • Bisson GP; Botswana-Upenn Partnership, Gaborone, Botswana. drewg1080@gmail.com.
  • Perfect JR; Botswana-Upenn Partnership, Gaborone, Botswana. haverkamp.bup@gmail.com.
  • Letang E; Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA. haverkamp.bup@gmail.com.
  • Fenner L; Botswana-Upenn Partnership, Gaborone, Botswana. gregbisson@me.com.
  • Meintjes G; Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA. gregbisson@me.com.
  • Burton R; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC, USA. john.perfect@dm.duke.edu.
  • Makadzange T; Swiss Tropical and Public Health Institute, Basel, Switzerland. emili.letang@unibas.ch.
  • Ndhlovu CE; Ifakara Health Institute, Ifakara, Morogoro, Tanzania. emili.letang@unibas.ch.
  • Hope W; ISGLOBAL, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clinic-Universitat de Barcelona, Barcelona, Spain. emili.letang@unibas.ch.
  • Harrison TS; Swiss Tropical and Public Health Institute, Basel, Switzerland. lukas.fenner@unibas.ch.
  • Jarvis JN; Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, Cape Town, South Africa. graemein@mweb.co.za.
Trials ; 16: 276, 2015 Jun 17.
Article em En | MEDLINE | ID: mdl-26081985

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluconazol / Anfotericina B / Meningite Criptocócica / Infecções Oportunistas Relacionadas com a AIDS / Coinfecção / Antifúngicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans País como assunto: Africa Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluconazol / Anfotericina B / Meningite Criptocócica / Infecções Oportunistas Relacionadas com a AIDS / Coinfecção / Antifúngicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans País como assunto: Africa Idioma: En Ano de publicação: 2015 Tipo de documento: Article